Lupin Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 27 @ ₹2110.00.
Lupin has an upper circuit limit of ₹2212.10 and a lower circuit limit of ₹1809.90. The total value traded stands at ₹0.00, and the delivery percentage for the day is 54.45%.
The stock is currently traded with a market lot size of 1. Lupin also offers a dividend yield of 0.9%.
Lupin Share Price Chart
Lupin Share Key Metrics
Volume
0.00
Market Cap
96488.18 CR
LTQ@LTP
27@2110.00
ATP
0
Var Margin
12.5 %
Circuit Range
1809.9-2212.1
Delivery %
54.45 %
Value
0.00
ASM/GSM
No
Market Lot
1
Lupin Resistance and Support
Pivot 1983.93
Resistance
First Resistance
2005.56
Second Resistance
2021.23
Third Resistance
2042.86
Support
First Support
1968.26
Second Support
1946.63
Third Support
1930.96
Lupin Futures & Options
2110
120.1 (6.04%)
Lupin Option Chain
View Price, OI, Greeks & More...
23NOV26
2011.40
16.60 (0.83%)
29DEC26
2024.00
15.80 (0.79%)
25JAN27
2016.00
0.00 (0.00%)
LUPIN|23NOV26 CE 2000.00
0.00
-53.7 (-100%)
LUPIN|23NOV26 PE 2020.00
0
0 (0%)
Lupin Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Lupin Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-08-06 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-17 | 2026-07-17 | View More |
Lupin News
Lupin Ltd - 500257 - General Updates
Lupin announced that the US FDA has issued a Form-483 with one observation for its Goa manufacturing facility. The inspection was conducted from October 19 to October 23, 2026.
Oct 24 2026 14:38:08
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Lupin grants 40,157 stock options under ESOP Scheme 2025.
Oct 19 2026 19:03:13
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin has secured US FDA approval for its ANDA for Phytonadione Injectable Emulsion USP. The drug, indicated for treating low blood clotting, has an estimated annual US market size of USD 52.3 million.
Oct 08 2026 20:58:27
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin launched Formoflo-G MDI, the world's first fixed-dose triple combination inhaler for COPD management in India, after receiving DCGI approval. The product combines three therapies in a single inhaler for twice-daily use.
Oct 06 2026 09:36:50
Lupin Management
| Name | Position |
|---|---|
| Manju D Gupta | Chairperson |
| Nilesh Gupta | Managing Director |
Lupin Similar Stocks
Zydus Lifesciences Ltd.
1120.00
-64.40 (5.44%)
Dr. Reddy's Laboratories Ltd.
1151.00
-194.00 (14.42%)
Cipla Ltd.
1497.90
139.90 (10.30%)
Mankind Pharma Ltd.
2327.90
-141.40 (5.73%)
Aurobindo Pharma Ltd.
1653.10
-6.80 (0.41%)
Manipal Health Enterprises Ltd.
723.00
84.20 (13.18%)
Max Healthcare Institute Ltd.
984.80
133.65 (15.70%)
Glenmark Pharmaceuticals Ltd.
2437.20
98.20 (4.20%)
Alkem Laboratories Ltd.
5190.00
111.00 (2.19%)
Aster DM Quality Care Ltd.
785.35
106.15 (15.63%)
Lupin FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in LUPIN
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC